Showing 1 - 20 results of 36 for search 'M. Blom', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
Visualization and clinical relevance of the endolymphatic duct and sac in Ménière's disease by Lisa M. H. de Pont, Lisa M. H. de Pont, Maartje T. P. M. Houben, Maartje T. P. M. Houben, Thijs O. Verhagen, Thijs O. Verhagen, Berit M. Verbist, Mark A. van Buchem, Claire C. Bommeljé, Henk M. Blom, Henk M. Blom, Henk M. Blom, Sebastiaan Hammer
Published 2023-08-01
Article -
6
Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression by Anna M. Blom, Chrysostomi Gialeli, Catharina Hagerling, Jonna Berntsson, Karin Jirström, Konstantinos S. Papadakos
Published 2023-05-01
Article -
7
-
8
Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner by Konstantinos S. Papadakos, Alexander Ekström, Piotr Slipek, Eleni Skourti, Steven Reid, Kristian Pietras, Anna M. Blom
Published 2022-12-01
Article -
9
-
10
-
11
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition by Gilar Gorji-Bahri, B. Madhu Krishna, Catharina Hagerling, Akira Orimo, Karin Jirström, Konstantinos S. Papadakos, Anna M. Blom
Published 2024-04-01
Article -
12
Biomarkers of Complement and Platelet Activation are not correlated with the One or Twenty-Four Hours Corrected Count Increments in Prophylactically Platelet Transfused Hematologic... by Alexander Åkesson, Marcus Ljungkvist, Myriam Martin, Anna M. Blom, Jenny Klintman, Ulf Schött, Eva Zetterberg, Thomas Kander
Published 2022-04-01
Article -
13
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy by Chrysostomi Gialeli, Emre Can Tuysuz, Johan Staaf, Safia Guleed, Veronika Paciorek, Matthias Mörgelin, Konstantinos S. Papadakos, Anna M. Blom
Published 2021-08-01
Article -
14
Complement activation negatively affects the platelet response to thrombopoietin receptor agonists in patients with immune thrombocytopenia: a prospective cohort study by Alexander Åkesson, James B. Bussel, Myriam Martin, Anna M. Blom, Jenny Klintman, Waleed Ghanima, Eva Zetterberg, Lamya Garabet
Published 2023-12-01
Article -
15
PB2300: COMPLEMENT ACTIVATION NEGATIVELY AFFECTS THE PLATELET RESPONSE TO THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY by A. Åkesson, J. B. Bussel, M. Martin, A. M. Blom, J. Klintman, W. Ghanima, E. Zetterberg, L. Garabet
Published 2022-06-01
Article -
16
-
17
Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy by Chrysostomi Gialeli, Emre Can Tuysuz, Johan Staaf, Safa Guleed, Veronika Paciorek, Matthias Mörgelin, Konstantinos S. Papadakos, Anna M. Blom
Published 2023-05-01
Article -
18
-
19
-
20
Ambipolar charge transport in a non-fullerene acceptor by Franziska H. Hasenburg, Kun-Han Lin, Bas van der Zee, Paul W. M. Blom, Denis Andrienko, Gert-Jan A. H. Wetzelaer
Published 2023-02-01
Article